Resmed Begin Period Cash Flow from 2010 to 2024

Stocks . Australia . 
Stock . Resmed Inc DRC
RMD Stock   38.19  0.13  0.34%   
Resmed Begin Period Cash Flow yearly trend continues to be comparatively stable with very little volatility. Begin Period Cash Flow is likely to outpace its year average in 2024. Begin Period Cash Flow is the amount of cash Resmed Inc DRC has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
1996-09-30
Previous Quarter
237.9 M
Current Value
238.4 M
Quarterly Volatility
311.1 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Resmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Resmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 227 M, Total Revenue of 4.9 B or Gross Profit of 2.8 B, as well as many indicators such as . Resmed financial statements analysis is a perfect complement when working with Resmed Valuation or Volatility modules.
  
This module can also supplement various Resmed Technical models . Check out the analysis of Resmed Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Resmed Stock Analysis

When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY